These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39074563)

  • 1. Emerging role of Metformin in Alzheimer's disease: A translational view.
    Ríos JA; Bórquez JC; Godoy JA; Zolezzi JM; Furrianca MC; Inestrosa NC
    Ageing Res Rev; 2024 Sep; 100():102439. PubMed ID: 39074563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes drugs in the fight against Alzheimer's disease.
    Boccardi V; Murasecco I; Mecocci P
    Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Markowicz-Piasecka M; Sikora J; Szydłowska A; Skupień A; Mikiciuk-Olasik E; Huttunen KM
    Pharm Res; 2017 Dec; 34(12):2614-2627. PubMed ID: 28589443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings.
    Khezri MR; Yousefi K; Mahboubi N; Hodaei D; Ghasemnejad-Berenji M
    Biochem Pharmacol; 2022 Mar; 197():114945. PubMed ID: 35134385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects.
    Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
    Inflammopharmacology; 2023 Jun; 31(3):1107-1115. PubMed ID: 36849855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the dual character of metformin in Alzheimer's disease.
    Ning P; Luo A; Mu X; Xu Y; Li T
    Neuropharmacology; 2022 Apr; 207():108966. PubMed ID: 35077762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones.
    Cardoso S; Moreira PI
    Int Rev Neurobiol; 2020; 155():37-64. PubMed ID: 32854858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insight into the role of metformin in Alzheimer's disease.
    Sanati M; Aminyavari S; Afshari AR; Sahebkar A
    Life Sci; 2022 Feb; 291():120299. PubMed ID: 34999113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
    Nowell J; Blunt E; Gupta D; Edison P
    Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
    Ali SK; Ali RH
    PLoS One; 2022; 17(7):e0271138. PubMed ID: 35802659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between Alzheimer's disease and diabetes: a focus on anti-diabetic drugs.
    Goodarzi G; Tehrani SS; Fana SE; Moradi-Sardareh H; Panahi G; Maniati M; Meshkani R
    Metab Brain Dis; 2023 Aug; 38(6):1769-1800. PubMed ID: 37335453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic Drugs in the Treatment of Alzheimer's Disease.
    Michailidis M; Tata DA; Moraitou D; Kavvadas D; Karachrysafi S; Papamitsou T; Vareltzis P; Papaliagkas V
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could metformin be therapeutically useful in Huntington's disease?
    Tang BL
    Rev Neurosci; 2020 Apr; 31(3):297-317. PubMed ID: 31751298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Envisioning the neuroprotective effect of Metformin in experimental epilepsy: A portrait of molecular crosstalk.
    H S N; Paudel YN; K L K
    Life Sci; 2019 Sep; 233():116686. PubMed ID: 31348946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus.
    de Winter W; DeJongh J; Post T; Ploeger B; Urquhart R; Moules I; Eckland D; Danhof M
    J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):313-43. PubMed ID: 16552630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?].
    García-Casares N; García-Arnés JA; Gómez-Huelgas R; Valdivielso-Felices P; García-Arias C; González-Santos P
    Rev Neurol; 2014 Dec; 59(11):517-24. PubMed ID: 25418147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.
    Femminella GD; Bencivenga L; Petraglia L; Visaggi L; Gioia L; Grieco FV; de Lucia C; Komici K; Corbi G; Edison P; Rengo G; Ferrara N
    J Diabetes Res; 2017; 2017():7420796. PubMed ID: 28656154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review].
    Ishmuratova AN; Abramov MA; Kuznetsov KO; Ivanyuta MV; Shakirova ZF; Kitapova AI; Usmonov MD; Chernousova LM; Valeeva LI; Kuznetsova AY; Baislamov AS; Shaihetdinova AR; Mirgaliev AA; Orozberdiev ST; Yakupova KI
    Probl Endokrinol (Mosk); 2023 Nov; 69(5):73-83. PubMed ID: 37968954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease.
    Cummings J; Ortiz A; Castellino J; Kinney J
    Eur J Neurosci; 2022 Nov; 56(9):5727-5757. PubMed ID: 35128745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.